Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sayed M Habib"'
Autor:
Sayed M Habib, Alferso C Abrahams, Mario R Korte, Robert Zietse, Lisette L de Vogel, Walther H Boer, Amélie Dendooven, Marian C Clahsen-van Groningen, Michiel G H Betjes
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0120174 (2015)
Encapsulating peritoneal sclerosis (EPS) is a severe complication of peritoneal dialysis (PD). Previously, it has been shown that infiltrating CD4-positive T cells and M2 macrophages are associated with several fibrotic conditions. Therefore, the cha
Externí odkaz:
https://doaj.org/article/90256b57ddf049d78e07a0b3e63bfdd5
Autor:
Alferso C Abrahams, Sayed M Habib, Amélie Dendooven, Bruce L Riser, Jan Willem van der Veer, Raechel J Toorop, Michiel G H Betjes, Marianne C Verhaar, Christopher J E Watson, Tri Q Nguyen, Walther H Boer
Publikováno v:
PLoS ONE, Vol 9, Iss 11, p e112050 (2014)
IntroductionEncapsulating peritoneal sclerosis (EPS) is a devastating complication of peritoneal dialysis (PD). The pathogenesis is not exactly known and no preventive strategy or targeted medical therapy is available. CCN2 has both pro-fibrotic and
Externí odkaz:
https://doaj.org/article/fc8d2500790e4b3380c87aa87f51bc20
Autor:
Joerg Latus, Sayed M Habib, Daniel Kitterer, Mario R Korte, Christoph Ulmer, Peter Fritz, Simon Davies, Mark Lambie, M Dominik Alscher, Michiel G H Betjes, Stephan Segerer, Niko Braun, European EPS study group
Publikováno v:
PLoS ONE, Vol 9, Iss 8, p e106511 (2014)
BackgroundEncapsulating peritoneal sclerosis (EPS) commonly presents after peritoneal dialysis has been stopped, either post-transplantation (PT-EPS) or after switching to hemodialysis (classical EPS, cEPS). The aim of the present study was to invest
Externí odkaz:
https://doaj.org/article/5a1fae7c5e3b4488b9e8f18b32b5dcb4
Autor:
Sayed M. Habib, Dick G. Struijk, Michiel G. H. Betjes, Aline C. Hemke, Mario R. Korte, Els W. Boeschoten, Alferso C. Abrahams, Ralph Westerhuis
Publikováno v:
Peritoneal Dialysis International, 37(2), 230-+. Multimed Inc.
Peritoneal dialysis international, 37(2), 230-234. Multimed Inc.
Peritoneal dialysis international, 37(2), 230-234. MULTIMED INC
Peritoneal dialysis international, 37(2), 230-234. Multimed Inc.
Peritoneal dialysis international, 37(2), 230-234. MULTIMED INC
The Dutch Encapsulating Peritoneal Sclerosis (EPS) Registry was started in 2009. Cases were identified by contacting all Dutch nephrologists twice yearly. The predefined criteria for EPS allowed for inclusion of patients with diagnosed and suspected
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a1deea2e713c6deeec17b4a58d39345
https://pure.eur.nl/en/publications/f774f143-3ee1-4546-ad34-b3fb7f6b6e63
https://pure.eur.nl/en/publications/f774f143-3ee1-4546-ad34-b3fb7f6b6e63
Autor:
Sayed M. Habib, Sander M. Hagen, Robert Zietse, Frank J. M. F. Dor, Mario R. Korte, Michiel G. H. Betjes
Publikováno v:
Peritoneal Dialysis International, 33(5), 503-506. Multimed Inc.
Background Encapsulating peritoneal sclerosis (EPS) is a rare complication of peritoneal dialysis (PD). It is characterized by encapsulation of the bowel, causing symptoms of intestinal obstruction. Exclusive involvement of parts of the bowel may occ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16a58523294681739e1bc335d56cb49d
https://doi.org/10.3747/pdi.2012.00105
https://doi.org/10.3747/pdi.2012.00105
Publikováno v:
American Journal of Nephrology, 37(3), 223-230. Karger
Background: Encapsulating peritoneal sclerosis (EPS) may occur after kidney transplantation (post-transplantation EPS) or may be diagnosed during or after peritoneal dialysis treatment (classical EPS). The aim of the present study was to investigate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4687ffad0099da260aa9ba81deda2045
https://hdl.handle.net/1765/65014
https://hdl.handle.net/1765/65014
Publikováno v:
BMC Nephrology, 14. BioMed Central Ltd.
BMC Nephrology
BMC Nephrology
Background Post-transplantation encapsulating peritoneal sclerosis (EPS) causing bowel obstruction has been identified as a serious complication after kidney transplantation in patients previously treated with peritoneal dialysis. Systemic inflammati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a726dc205f1cb1f0fe5bf17aef12897
https://pure.eur.nl/en/publications/8d0cabd6-d156-41de-bb0b-281b2f178da6
https://pure.eur.nl/en/publications/8d0cabd6-d156-41de-bb0b-281b2f178da6
Autor:
Walther H. Boer, Marianne C. Verhaar, Jan Willem van der Veer, Raechel J. Toorop, Michiel G. H. Betjes, Chris J Watson, Bruce L. Riser, Sayed M. Habib, Tri Q. Nguyen, Alferso C. Abrahams, Amélie Dendooven
Publikováno v:
PLoS ONE
PLOS ONE
PLoS ONE, Vol 9, Iss 11, p e112050 (2014)
PLoS One (print), 9(11). Public Library of Science
PLOS ONE
PLoS ONE, Vol 9, Iss 11, p e112050 (2014)
PLoS One (print), 9(11). Public Library of Science
IntroductionEncapsulating peritoneal sclerosis (EPS) is a devastating complication of peritoneal dialysis (PD). The pathogenesis is not exactly known and no preventive strategy or targeted medical therapy is available. CCN2 has both pro-fibrotic and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44a971a290fa41b3a893fd6dd41abf47
https://doi.org/10.1371/journal.pone.0112050
https://doi.org/10.1371/journal.pone.0112050